Exact Sciences Corp (MEX:EXAS)
MXN 872 0 (0%) Market Cap: 217.13 Bil Enterprise Value: 252.21 Bil PE Ratio: 0 PB Ratio: 3.40 GF Score: 80/100

Exact Sciences Corp at Barclays Global Healthcare Conference Transcript

Mar 13, 2019 / 05:35PM GMT
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

I'm Jack Meehan, the life science tools and diagnostics analyst at Barclays, and really thrilled to be hosting Exact Sciences and CFO, Jeff Elliott.

I also have Megan Jones from the Investor Relations team here. So before we kick it off, we're going to do 3 audience response questions. So use the blackberry-type devices. Question one, what do you view as Exact's organic growth rate over the next 3-year period? So CAGR will get to the -- we use the same question for every company, but we'll see if they agree on the growth.

(Voting)

Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

Might have needed a higher double-digit range, 64%.

Number two, do you expect organic growth to accelerate from these levels and when? What is your organic growth rate forecast for '19?

Jeffrey T. Elliott
Exact Sciences Corporation - CFO

It's in the double digits. Okay. So it got to be better

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot